The Neurology Channel

Rasagiline Meets Primary Endpoints in ADAGIO Trial

From VerusMed Neurology

1:19 | Neurology

Rasagiline 1 mg tablets slow the progression of Parkinson’s disease, according to Phase III trial data.

From our partners at VerusMed
VerusMed.com

More in Neurology

►

The Use of Virtual Reality for Pre-Procedural Planning and Practicing

Internal Medicine

Erik F. Wang, James Yu, DO, MS, John E. Rubin, MD, and Rohan Jotwani, MD, of the Department of Anesthesiology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, describe the use...

► 1:29:36

How Can Metastatic Brain Tumors Affect Lung Cancer Care?

Erin Dunbar, MD, director of Neuro-Oncology, Piedmont Atlanta Hospital, Atlanta, GA; Minesh Mehta, MD, chief of Radiotherapy, Baptist Health South Florida; Rohan Ramakrishna, MD, neurosurgeon, Weil Cornell Medical Center, New...

► 26:24

Novel Strategies for Treating Meningiomas

Neurology

Nancy Ann Oberheim Bush, MD, PhD, University of California San Francisco, discusses current and emerging devices and therapies for the management of meningiomas. Dr Oberheim Bush also noted that the...

► 22:47

Metastatic Brain Tumor Management

Neurology

Seema Nagpal, MD, Stanford University, Stanford, CA, discusses therapeutic options for the management of metastatic brain tumors. Dr Nagpal explains how the careful use of surgery, radiation, and targeted therapy...